Trade Summary
3 days ago, Column Group III Gp, LP, serving as 10% owner at Tenaya Therapeutics, Inc. (TNYA), sold 4,170,266 shares at $0.57 per share, for a total transaction value of $2,380,189.00. Following this transaction, Column Group III Gp, LP now holds 49,313,559 shares of TNYA.
This sale represents a 8.00% decrease in Column Group III Gp, LP's stake in the company. This is considered a high-conviction trade given the significant change in ownership.
The trade was executed on Tuesday, February 24, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, February 26, 2026, 2 days after the trade was made.
Tenaya Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.
